Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Thanan, Raynoo ^a,b   Murata, Mariko ^b   Ma, Ning ^a   Hammam, Olfat ^c   Wishahi, Mohamed ^c   El Leithy, Tarek ^c   Hiraku, Yusuke ^b   Oikawa, Shinji ^b   Kawanishi, Shosuke ^a,b  

^a SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b MIE UNIVERSITY   (Japan)

^c THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V6 ANTIGEN; CYCLOOXYGENASE 2; OCTAMER TRANSCRIPTION FACTOR 4; HERMES ANTIGEN; POU5F1 PROTEIN, HUMAN;

ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CANCER RISK; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTITIS; CYTOPLASM; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SCHISTOSOMIASIS HAEMATOBIA; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; UPREGULATION; ANIMAL; BIOSYNTHESIS; BLADDER TUMOR; CELL NUCLEUS; CYTOLOGY; ENZYMOLOGY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; INFLAMMATION; METABOLISM; METHODOLOGY; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; STEM CELL;

SCHISTOSOMA HAEMATOBIUM;

ANIMALS; ANTIGENS, CD44; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICROSCOPY, FLUORESCENCE; OCTAMER TRANSCRIPTION FACTOR-3; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS; STEM CELLS; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 84861044820     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/165879     Document Type: Article

References (59)

1. Grivennikov S. I., Greten F. R., Karin M., Immunity, inflammation, and cancer Cell 2010 140 6 883 899
2. La Vecchia C., Negri E., D'Avanzo B., Savoldelli R., Franceschi S., Genital and urinary tract diseases and bladder cancer Cancer Research 1991 51 2 629 631
3. Michaud D. S., Chronic inflammation and bladder cancer Urologic Oncology 2007 25 3 260 268 (Pubitemid 46670749)
4. IARC, Schistosomes, liver flukes and Helicobacter pylori IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 714 June 1994 IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 1994 61 1 241
5. Rollinson D., A wake up call for urinary schistosomiasis: reconciling research effort with public health importance Parasitology 2009 136 12 1593 1610
6. Vennervald B. J., Polman K., Helminths and malignancy Parasite Immunology 2009 31 11 686 696
7. Ohnishi S., Murata M., Kawanishi S., Oxidative DNA damage induced by a metabolite of 2-naphthylamine, a smoking-related bladder carcinogen Japanese Journal of Cancer Research 2002 93 7 736 743
8. Shopland D. R., Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking Environmental Health Perspectives 1995 103 supplement 8 131 142 (Pubitemid 26040889)
9. Bartkova J., Guldberg P., Grnbaek K., Koed K., Primdahl H., Mller K., Lukas J., rntoft T. F., Bartek J., Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer Oncogene 2004 23 52 8545 8551 (Pubitemid 39540805)
10. Hornigold N., Devlin J., Davies A. M., Aveyard J. S., Habuchi T., Knowles M. A., Mutation of the 9q34 gene TSC1 in sporadic bladder cancer Oncogene 1999 18 16 2657 2661 (Pubitemid 29216689)
11. Sanchez-Carbayo M., Socci N. D., Kirchoff T., Erill N., Offit K., Bochner B. H., Cordon-Cardo C., A polymorphismin HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer Clinical Cancer Research 2007 13 11 3215 3220 (Pubitemid 46944904)
12. Srivastava D. S., Mandhani A., Mittal R. D., Genetic polymorphisms of cytochrome P450 CYP1A1 (2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India Archives of Toxicology 2008 82 9 633 639
13. Srivastava D. S., Mishra D. K., Mandhani A., Mittal B., Kumar A., Mittal R. D., Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer European Urology 2005 48 2 339 344 (Pubitemid 40957115)
14. Reya T., Morrison S. J., Clarke M. F., Weissman I. L., Stem cells, cancer, and cancer stem cells Nature 2001 414 6859 105 111 (Pubitemid 33041634)
15. Shipitsin M., Polyak K., The cancer stem cell hypothesis: in search of definitions, markers, and relevance Laboratory Investigation 2008 88 5 459 463 (Pubitemid 351581449)
16. Atlasi Y., Mowla S. J., Ziaee S. A. M., Bahrami A. R., OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer International Journal of Cancer 2007 120 7 1598 1602 (Pubitemid 46355399)
17. Chang C. C., Shieh G. S., Wu P., Lin C. C., Shiau A. L., Wu C. L., Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells Cancer Research 2008 68 15 6281 6291
18. Bentivegna A., Conconi D., Panzeri E., Sala E., Bovo G., Vigan P., Brunelli S., Bossi M., Tredici G., Strada G., Dalpr L., Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples Cancer Science 2010 101 2 416 424
19. Ma N., Thanan R., Kobayashi H., Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosomahaematobium infection Biochemical and Biophysical Research Communications 2011 414 2 344 349
20. Klatte T., Seligson D. B., Rao J. Y., Yu H., de Martino M., Garraway I., Wong S. G., Belldegrun A. S., Pantuck A. J., Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome Journal of Urology 2010 183 6 2403 2408
21. Iczkowski K. A., Shanks J. H., Bostwick D. G., Loss of CD44 variant 6 expression differentiates small cell carcinoma of urinary bladder from urothelial (transitional cell) carcinoma Histopathology 1998 32 4 322 327 (Pubitemid 28186590)
22. Ross J. S., del Rosario A. D., Bui H. X., Kallakury B. V. S., Okby N. T., Figge J., Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma Modern Pathology 1996 9 8 854 860 (Pubitemid 26279277)
23. Kuncov J., Urban M., Mandys V., Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells APMIS 2007 115 11 1194 1205 (Pubitemid 350293946)
24. Sugiyama M., Woodman A., Sugino T., Crowley S., Ho K., Smith J., Matsumura Y., Tarin D., Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine Journal of Clinical Pathology 1995 48 3 M142 M147
25. Yang Y. M., Chang J. W., Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells Cancer Investigation 2008 26 7 725 733
26. Jijiwa M., Demir H., Gupta S., Leung C., Joshi K., Orozco N., Huang T., Yildiz V. O., Shibahara I., de Jesus J. A., Yong W. H., Mischel P. S., Fernandez S., Kornblum H. I., Nakano I., CD44V6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway Plos ONE 2011 6 9
27. North T. E., Goessling W., Walkley C. R., Lengerke C., Kopani K. R., Lord A. M., Weber G. J., Bowman T. V., Jang I. H., Grosser T., Fitzgerald G. A., Daley G. Q., Orkin S. H., Zon L. I., Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis Nature 2007 447 7147 1007 1011 (Pubitemid 46975751)
28. Logan C. M., Giordano A., Puca A., Cassone M., Prostaglandin E2: at the crossroads between stem cell development, inflammation and cancer Cancer Biology and Therapy 2007 6 10 1517 1520 (Pubitemid 351590320)
29. Kitayama W., Denda A., Okajima E., Tsujiuchi T., Konishi Y., Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N -butyl- N -(4-hydroxybutyl) nitrosamine Carcinogenesis 1999 20 12 2305 2310 (Pubitemid 30015903)
30. Okajima E., Denda A., Ozono S., Takahama M., Akai H., Sasaki Y., Kitayama W., Wakabayashi K., Konishi Y., Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N -butyl- N (4-hydroxybutyl) nitrosamine Cancer Research 1998 58 14 3028 3031 (Pubitemid 28335083)
31. Ristimki A., Nieminen O., Saukkonen K., Hotakainen K., Nordling S., Haglund C., Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder American Journal of Pathology 2001 158 3 849 853 (Pubitemid 32221778)
32. Shirahama T., Sakakura C., Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder Clinical Cancer Research 2001 7 3 558 561 (Pubitemid 32707978)
33. Hammam O. A., Aziz A. A., Roshdy M. S., Abdel Hadi A. M., Possible role of cyclooxygenase-2 in schistosomal and non-schistosomal-associated bladder cancer Medscape General Medicine 2008 10 3, article 60
34. Eble J. N., Sauter G., Epstein J. I., Sesterhenn I. A., World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs 2004 Lyon, France IARC Press
35. Mostofi F. K., Sobin L. H., Torloni H., Histological Typing of Urinary Bladder Tumours: International Classification of Tumours 1973 10 Geneva, Switzerland World Health Organization
36. Shaker Z. A., Kaddah M. A., Hanallah S. B., El-Khodary M. I., Production of monoclonal antibodies against target schistosomal antigen secreted in the urine of Schistosoma mansoni -infected patients International Journal for Parasitology 1998 28 12 1893 1901 (Pubitemid 29017724)
37. Ma N., Adachi Y., Hiraku Y., Horiki N., Horiike S., Imoto I., Pinlaor S., Murata M., Semba R., Kawanishi S., Accumulation of 8-nitroguanine in human gastric epithelium induced by Helicobacter pylori infection Biochemical and Biophysical Research Communications 2004 319 2 506 510 (Pubitemid 38725975)
38. Coussens L. M., Werb Z., Inflammation and cancer Nature 2002 420 6917 860 867 (Pubitemid 36019639)
39. Rakoff-Nahoum S., Why cancer and inflammation? Yale Journal of Biology and Medicine 2006 79 3-4 123 130
40. Maitland N. J., Collins A. T., Inflammation as the primary aetiological agent of human prostate cancer: a stem cell connection? Journal of Cellular Biochemistry 2008 105 4 931 939
41. Tanno T., Matsui W., Development and maintenance of cancer stem cells under chronic inflammation Journal of Nippon Medical School 2011 78 3 138 145
42. Hoggatt J., Singh P., Sampath J., Pelus L. M., Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation Blood 2009 113 22 5444 5455
43. Yun H. K., Ho J. H., High-glucose-induced prostaglandin E2 and peroxisome proliferator-activated receptor promote mouse embryonic stem cell proliferation Stem Cells 2008 26 3 745 755
44. Liou J. Y., Ellent D. P., Lee S., Goldsby J., Ko B. S., Matijevic N., Huang J. C., Wu K. K., Cyclooxygenase-2-derived prostaglandin E2 protects mouse embryonic stem cells from apoptosis Stem Cells 2007 25 5 1096 1103 (Pubitemid 46684868)
45. Yun S. P., Ryu J. M., Jang M. W., Han H. J., Interaction of profilin-1 and F-actin via a -arrestin-1/JNK signaling pathway involved in prostaglandin E2-induced human mesenchymal stem cells migration and proliferation Journal of Cellular Physiology 2011 226 2 559 571
46. Rudnick J. A., Arendt L. M., Klebba I., Hinds J. W., Iyer V., Gupta P. B., Naber S. P., Kuperwasser C., Functional heterogeneity of breast fibroblasts is defined by a prostaglandin secretory phenotype that promotes expansion of cancer-stem like cells Plos ONE 2011 6 9
47. Maroni P., Matteucci E., Luzzati A., Perrucchini G., Bendinelli P., Desiderio M. A., Nuclear co-localization and functional interaction of COX-2 and HIF-1 characterize bone metastasis of human breast carcinoma Breast Cancer Research and Treatment 2011 129 2 433 450
48. Parfenova H., Parfenov V. N., Shlopov B. V., Levine V., Falkos S., Pourcyrous M., Leffler C. W., Dynamics of nuclear localization sites for COX-2 in vascular endothelial cells American Journal of Physiology 2001 281 1 C166 C178
49. Burdon T., Smith A., Savatier P., Signalling, cell cycle and pluripotency in embryonic stem cells Trends in Cell Biology 2002 12 9 432 438 (Pubitemid 35239952)
50. Rosner M. H., Vigano M. A., Ozato K., Timmons P. M., Poirier F., Rigby P. W. J., Staudt L. M., A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo Nature 1990 345 6277 686 692
51. Okita K., Ichisaka T., Yamanaka S., Generation of germline-competent induced pluripotent stem cells Nature 2007 448 7151 313 317 (Pubitemid 47080336)
52. Park I. H., Zhao R., West J. A., Yabuuchi A., Huo H., Ince T. A., Lerou P. H., Lensch M. W., Daley G. Q., Reprogramming of human somatic cells to pluripotency with defined factors Nature 2008 451 7175 141 146
53. Yu J., Vodyanik M. A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J. L., Tian S., Nie J., Jonsdottir G. A., Ruotti V., Stewart R., Slukvin I. I., Thomson J. A., Induced pluripotent stem cell lines derived from human somatic cells Science 2007 318 5858 1917 1920
54. Chen Y. C., Hsu H. S., Chen Y. W., Tsai T. H., How C. K., Wang C. Y., Hung S. C., Chang Y. L., Tsai M. L., Lee Y. Y., Ku H. H., Chiou S. H., Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells PLoS ONE 2008 3 7
55. Ponti D., Costa A., Zaffaroni N., Pratesi G., Petrangolini G., Coradini D., Pilotti S., Pierotti M. A., Daidone M. G., Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties Cancer Research 2005 65 13 5506 5511 (Pubitemid 40911148)
56. Ponta H., Sherman L., Herrlich P. A., CD44: from adhesion molecules to signalling regulators Nature Reviews Molecular Cell Biology 2003 4 1 33 45 (Pubitemid 36077255)
57. Tanabe K. K., Ellis L. M., Saya H., Expression of CD44R1 adhesion molecule in colon carcinomas and metastases The Lancet 1993 341 8847 725 726 (Pubitemid 23085181)
58. Croker A. K., Allan A. L., Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDH(hi)CD44 (+) human breast cancer cells Breast Cancer Research and Treatment 2011 1 13
59. Ishimoto T., Nagano O., Yae T., CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth Cancer Cell 2011 19 3 387 400